The treatment effectively inhibited the expression of MMP-2 and MMP-9 in tumor tissue, assessed by immunohistochemical staining, and significantly decreased the tumor volume, indicating that EGCG has strong anti-cancer activity in vivo [56]. The gene discussed is MMP2; the disease is cancer.